Mild cognitive impairment in a clinically latent HIV-1 patient population

Mild cognitive impairment in a clinically latent HIV-1 patient population

Bibliographic Details
Main Authors:	K.N. Devlin, T. Giovannetti, W. Dampier, V. Pirrone, M.R. Nonnemacher, E. Schell, C. Lamberson, J.R. Kurczewski, J.M. Jacobson, D.J. Libon, B. Wigdahl
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020313790

Similar Items

Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals.
by: Ashley Azar, et al.
Published: (2016-01-01)

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015-12-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019-12-01)

Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort
by: M.R. Nonnemacher, et al.
Published: (2017-12-01)

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
by: M. Nonnemacher, et al.
Published: (2015-12-01)

Genetic variation continues to occur in well-controlled HIV-1-infected patients
by: W. Dampier, et al.
Published: (2015-12-01)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015-12-01)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017-12-01)

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01)

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
by: Satinder Dahiya, et al.
Published: (2014-01-01)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
by: Alexander G. Allen, et al.
Published: (2018-12-01)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019-12-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

Impact of Viral Activators and Epigenetic Regulators on HIV-1 LTRs Containing Naturally Occurring Single Nucleotide Polymorphisms
by: Sonia Shah, et al.
Published: (2015-01-01)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
by: Natalia Roberto, et al.
Published: (2021-03-01)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01)

Cognitive Correlates of Digital Clock Drawing Metrics in Older Adults with and without Mild Cognitive Impairment
by: Dion, Catherine, et al.
Published: (2021)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
by: Monique E Maubert, et al.
Published: (2016-01-01)

Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center
by: John J. Hanfelt, et al.
Published: (2018-09-01)

Re: Insomnia and Mild Cognitive Impairment
by: S. M. J. Mortazavi PhD
Published: (2018-07-01)

Mild cognitive impairment
by: Pavlović Dragan M., et al.
Published: (2009-01-01)

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
by: Michael R. Nonnemacher, et al.
Published: (2017-04-01)

Assessing the capacity for mental manipulation in patients with statically-determined mild cognitive impairment using digital technology
by: Sheina Emrani, et al.
Published: (2021-02-01)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
by: Anupam Banerjee, et al.
Published: (2017-03-01)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.
by: Will Dampier, et al.
Published: (2016-01-01)

Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization
by: Ferrucci Adriano, et al.
Published: (2011-08-01)

Insomnia and Mild Cognitive Impairment
by: R. C. Hamdy MD, et al.
Published: (2018-05-01)

Patterns of Semantic Memory Impairment in Mild Cognitive Impairment
by: Sven Joubert, et al.
Published: (2008-01-01)

Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment
by: Malek-Ahmadi Michael, et al.
Published: (2012-02-01)

Region-specific Distribution of HIV-1 LTR C/EBP Site II Configurations in Demented and Non-demented Patients
by: Gartner Suzanne, et al.
Published: (2005-12-01)

Development of a Human Bone Marrow Progenitor Cell Line to Examine HIV-1 Susceptibility and LTR Activity
by: Wigdahl Brian, et al.
Published: (2005-12-01)

Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood–Brain Barrier
by: Marianne Strazza, et al.
Published: (2016-06-01)

Nasal diphtheria, with special reference to mild and latent forms
by: Fletcher, James
Published: (1902)

Use of HIV-1 LTR Sequence Variants as Prognostic Indicators of HIV Dementia
by: Wigdahl Brian, et al.
Published: (2005-12-01)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
by: Atsuko Hayashi, et al.
Published: (2015-09-01)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
by: Xiong Jiang, et al.
Published: (2021-01-01)

Oral function of older people with mild cognitive impairment or dementia
by: Delwel, S., et al.
Published: (2018)

Efficacy of Cellex in patients with mild cognitive impairment
by: B. A. Abusueva, et al.
Published: (2019-04-01)